Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onur Ozhan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pathology Research International|January 6, 2012
Behcet's Disease and Endocrine SystemOnur Ozhan, Kerem Sezer
Clinical Chemistry and Laboratory Medicine|January 15, 2013
Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary studyKenan Turgutalp, Onur Ozhan, Ilter Helvacı, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 17, 2007
Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern AnatoliaEmin Kaya, Mehmet Ali Erkurt, Ismet Aydogdu, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 30, 2012
Does the MRI or MRI contrast medium gadopentetate dimeglumine change the oxidant and antioxidant status in humans?Refik Olmaz, Kenan Turgutalp, Ebru Gok Oguz, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 22, 2008
Effects of cyanocobalamin on immunity in patients with pernicious anemiaMehmet Ali Erkurt, Ismet Aydogdu, Mustafa Dikilitaş, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|June 12, 2014
An unusual cause of duodenal obstruction: mesenteric fibromatosis in a patient with type I Mayer-Rokitansky-Kuster-Hauser syndromeKenan Turgutalp, Feray Tabakan, Tuğba Kara, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|November 7, 2013
Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injuryEbru Gok Oguz, Ahmet Kiykim, Kenan Turgutalp, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pathology Research International|January 6, 2012
Behcet's Disease and Endocrine SystemOnur Ozhan, Kerem Sezer
Clinical Chemistry and Laboratory Medicine|January 15, 2013
Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary studyKenan Turgutalp, Onur Ozhan, Ilter Helvacı, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 17, 2007
Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern AnatoliaEmin Kaya, Mehmet Ali Erkurt, Ismet Aydogdu, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 30, 2012
Does the MRI or MRI contrast medium gadopentetate dimeglumine change the oxidant and antioxidant status in humans?Refik Olmaz, Kenan Turgutalp, Ebru Gok Oguz, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 22, 2008
Effects of cyanocobalamin on immunity in patients with pernicious anemiaMehmet Ali Erkurt, Ismet Aydogdu, Mustafa Dikilitaş, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|June 12, 2014
An unusual cause of duodenal obstruction: mesenteric fibromatosis in a patient with type I Mayer-Rokitansky-Kuster-Hauser syndromeKenan Turgutalp, Feray Tabakan, Tuğba Kara, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|November 7, 2013
Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injuryEbru Gok Oguz, Ahmet Kiykim, Kenan Turgutalp, et al.
Pageof 1